Full Text View
Tabular View
Study Results
Related Studies
Pharmacogenomics in Autism Treatment (PG)
This study has been completed.
Study NCT00584701   Information provided by University of California, San Francisco

First Received on December 22, 2007.   Last Updated on June 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autism
Additional conditions recognized in this trial
Autistic Disorder
More general conditions related to this trial
Child Development Disorders, Pervasive
Mental Disorders
Mental Disorders Diagnosed in Childhood
Interventions listed in this trial
Risperidone
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University of California, San Francisco
Janssen, LP
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services